Security National Bank of SO Dak increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 31.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,504 shares of the pharmacy operator’s stock after acquiring an additional 2,988 shares during the quarter. Security National Bank of SO Dak’s holdings in CVS Health Corporation were worth $981,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently bought and sold shares of CVS. Mercer Capital Advisers Inc. bought a new stake in shares of CVS Health Corporation in the 1st quarter worth approximately $118,000. SRS Capital Advisors Inc. lifted its stake in shares of CVS Health Corporation by 48.2% in the 1st quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock valued at $177,000 after purchasing an additional 734 shares during the period. Cue Financial Group Inc. lifted its stake in shares of CVS Health Corporation by 3.6% in the 1st quarter. Cue Financial Group Inc. now owns 2,708 shares of the pharmacy operator’s stock valued at $213,000 after purchasing an additional 95 shares during the period. Pettee Investors Inc. purchased a new position in shares of CVS Health Corporation in the 1st quarter valued at approximately $214,000. Finally, Diversified Trust Co purchased a new position in shares of CVS Health Corporation in the 1st quarter valued at approximately $229,000. Institutional investors and hedge funds own 81.55% of the company’s stock.
A number of research analysts have recently commented on CVS shares. Vetr upgraded CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $85.96 target price for the company in a research note on Wednesday, May 17th. ValuEngine cut CVS Health Corporation from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Jefferies Group LLC restated a “hold” rating and issued a $82.00 target price on shares of CVS Health Corporation in a research note on Friday, June 9th. Cowen and Company restated an “outperform” rating and issued a $86.00 target price on shares of CVS Health Corporation in a research note on Tuesday, June 13th. Finally, Leerink Swann set a $90.00 target price on CVS Health Corporation and gave the company a “buy” rating in a research note on Tuesday, June 27th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and fourteen have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $90.83.
In other news, Director Richard J. Swift sold 2,500 shares of the firm’s stock in a transaction dated Wednesday, August 16th. The stock was sold at an average price of $79.62, for a total transaction of $199,050.00. Following the sale, the director now directly owns 3,258 shares in the company, valued at approximately $259,401.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Helena Foulkes sold 20,333 shares of the firm’s stock in a transaction dated Monday, June 26th. The shares were sold at an average price of $80.00, for a total value of $1,626,640.00. Following the sale, the executive vice president now owns 59,301 shares in the company, valued at $4,744,080. The disclosure for this sale can be found here. Insiders have sold a total of 43,165 shares of company stock worth $3,390,847 over the last 90 days. Insiders own 0.61% of the company’s stock.
CVS Health Corporation (CVS) traded up 2.60% during trading on Tuesday, hitting $81.79. The stock had a trading volume of 2,757,503 shares. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $91.82. The firm’s 50-day moving average price is $78.37 and its 200-day moving average price is $78.89. The company has a market cap of $83.14 billion, a price-to-earnings ratio of 16.29 and a beta of 0.92.
CVS Health Corporation (NYSE:CVS) last posted its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, beating the Zacks’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The firm had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $45.36 billion. During the same period last year, the firm earned $1.32 EPS. The company’s quarterly revenue was up 4.5% on a year-over-year basis. Analysts predict that CVS Health Corporation will post $5.88 EPS for the current fiscal year.
CVS Health Corporation Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.